111.9
[1]. J.-M. Michot, et al. A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF CC-99 ALONE AND IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY NON-HODGKIN LYMPHOMAS. Hematological Oncology. Volume 39, Issue S, Jun. 01.
H30-H315-H319-H335
P61-P64-P0-P1-P0-P30+P35-P304+P340-P305+P351+P33-P330-P36+P364-P403+P33-P405-P501
GHS0